People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Software / Tech, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JenaValve Technology Inc | — | Software / Tech | Series D+ | $328.5M | $2.2B | 2016 |
| Myoscience, Inc | — | Other | Series B | $122.6M | $83.1M | 2016 |
| 4Tech, Inc. | — | Biotechnology | Series B | $62.3M | $1.1B | 2015 |
Jan Pensaert at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jan Pensaert on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rudi Marien | 3 | 3 |
| Peter Barrett | 1 | 18 |
| Richard Ferrari | 1 | 15 |
| Robert Grant | 1 | 12 |
| Robert Mitchell | 1 | 9 |
| Anthony Lando | 1 | 6 |
| Richard M. Ferrari | 1 | 5 |
| Brian Farley | 1 | 5 |
| Andrew Hack | 1 | 5 |
| Quan Zhou | 1 | 5 |
| Clint Carnell | 1 | 4 |
| Cary . Vance | 1 | 4 |
| Lawrence C. Best | 1 | 4 |
| Benjamin Tsai | 1 | 4 |
| Thomas E. Hancock | 1 | 3 |
| Jon Serbousek | 1 | 3 |
| Thomas Weldon | 1 | 3 |
| Kenneth MacLeod | 1 | 3 |
| Jeffrey M. Nugent | 1 | 2 |
| Robert M. Curtis | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.